再战
2021-02-05
这篇文章不错,转发给大家看看
Cannabis Stocks Pop on News of Jazz-GW Merger
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":317715782,"tweetId":"317715782","gmtCreate":1612485478546,"gmtModify":1703762507183,"author":{"id":3456483327764574,"authorId":3456483327764574,"authorIdStr":"3456483327764574","name":"再战","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>这篇文章不错,转发给大家看看</p></body></html>","htmlText":"<html><head></head><body><p>这篇文章不错,转发给大家看看</p></body></html>","text":"这篇文章不错,转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/317715782","repostId":2108793032,"repostType":2,"repost":{"id":"2108793032","pubTimestamp":1612388873,"share":"https://www.laohu8.com/m/news/2108793032?lang=&edition=full","pubTime":"2021-02-04 05:47","market":"us","language":"en","title":"Cannabis Stocks Pop on News of Jazz-GW Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2108793032","media":"Investopedia","summary":"Cannabis Stocks Pop on News of Jazz-GW MergerJazz Pharmaceuticals agreed to acquire GW Pharmaceutica","content":"<h1>Cannabis Stocks Pop on News of Jazz-GW Merger</h1><h2>Jazz Pharmaceuticals agreed to acquire GW Pharmaceuticals for $7.2 billion</h2><ul><li></li><li>FACEBOOK</li><li></li><li>TWITTER</li><li></li><li>LINKEDIN</li></ul><p>By</p><p></p><p>Elana Dure</p><p>Updated Feb 3, 2021</p><p>Jazz Pharmaceuticals has agreed to acquire GW Pharmaceuticals, maker of the first epilepsy drug derived from marijuana, for $7.2 billion in cash and stock.</p><p>The deal, which combines the two biopharmaceutical companies, signifies Jazz’s bet on the long-term prospects of cannabis-based therapies.</p><p>Jazz will pay $200 in cash and $20 in stock per GW share. The transaction is expected to close in the second quarter.</p><p>Cannabis stocks jumped on the news, with shares in Cassava Sciences, Sundial Growers, and Tilray closing up 59%, 16%, and 12%, respectively, on Wednesday.</p><p><img src=\"http://:0\" referrerpolicy=\"no-referrer\"></p><p>Cannabis investors are also optimistic after three Democratic Senators released a statement supporting the decriminalization of marijuana.</p><p>GW’s drug Epidiolex is used to treat rare forms of epilepsy and had global sales of $510 million within two years of its 2018 launch. The deal will strengthen Jazz’s neuroscience portfolio, said Jazz CEO and Chairman Bruce Cozadd.</p><p>\"We have a shared vision of developing and commercializing innovative medicines that address significant unmet needs in neuroscience and an approach of putting patients first,” GW CEO Justin Gover said. “Together, we will have an opportunity to reach and impact more patients through a broader portfolio of neuroscience-focused therapies than ever before.\"</p><p>Shares in GW closed upy 44.5% on the news Wednesday, while shares in Jazz closed down nearly 4%.</p><h3>Article Sources</h3><p>Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our</p><p>editorial policy.</p><ol><li><p>Jazz Pharmaceuticals. \"Jazz Pharmaceuticals to Acquire <a href=\"https://laohu8.com/S/GWPH\">GW Pharmaceuticals plc</a>, Creating an Innovative, High-Growth, Global Biopharma Leader.\" Accessed Feb. 3, 2021.</p></li><li><p>The Wall Street Journal. \"Jazz Pharmaceuticals to Buy Cannabis-Based Drugmaker GW Pharma for $6.7 Billion.\" Accessed Feb 3, 2021.</p></li></ol><p>Compare Accounts</p><p>Advertiser Disclosure</p><p>×The offers that appear in this table are from partnerships from which Investopedia receives compensation.ProviderNameDescription<img referrerpolicy=\"no-referrer\"></p><ul><li>About Us</li><li>Terms of Use</li><li>Dictionary</li><li>Editorial Policy</li><li>Advertise</li><li>News</li><li>Privacy Policy</li><li>Contact Us</li><li>Careers</li><li>California Privacy Notice</li></ul><ul><li>#</li><li>A</li><li>B</li><li>C</li><li>D</li><li>E</li><li>F</li><li>G</li><li>H</li><li>I</li><li>J</li><li>K</li><li>L</li><li>M</li><li>N</li><li>O</li><li>P</li><li>Q</li><li>R</li><li>S</li><li>T</li><li>U</li><li>V</li><li>W</li><li>X</li><li>Y</li><li>Z</li></ul><p></p><p>Investopedia is part of the Dotdash publishing family.</p><p></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis Stocks Pop on News of Jazz-GW Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis Stocks Pop on News of Jazz-GW Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-04 05:47 GMT+8 <a href=https://www.investopedia.com/cannabis-stocks-pop-on-news-of-jazz-gw-merger-5104668?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo><strong>Investopedia</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cannabis Stocks Pop on News of Jazz-GW MergerJazz Pharmaceuticals agreed to acquire GW Pharmaceuticals for $7.2 billionFACEBOOKTWITTERLINKEDINByElana DureUpdated Feb 3, 2021Jazz Pharmaceuticals has ...</p>\n\n<a href=\"https://www.investopedia.com/cannabis-stocks-pop-on-news-of-jazz-gw-merger-5104668?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GWPH":"GW Pharmaceuticals plc","SAVA":"Cassava Sciences Inc","JAZZ":"爵士制药","TLRY":"Tilray Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.investopedia.com/cannabis-stocks-pop-on-news-of-jazz-gw-merger-5104668?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral&yptr=yahoo","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2108793032","content_text":"Cannabis Stocks Pop on News of Jazz-GW MergerJazz Pharmaceuticals agreed to acquire GW Pharmaceuticals for $7.2 billionFACEBOOKTWITTERLINKEDINByElana DureUpdated Feb 3, 2021Jazz Pharmaceuticals has agreed to acquire GW Pharmaceuticals, maker of the first epilepsy drug derived from marijuana, for $7.2 billion in cash and stock.The deal, which combines the two biopharmaceutical companies, signifies Jazz’s bet on the long-term prospects of cannabis-based therapies.Jazz will pay $200 in cash and $20 in stock per GW share. The transaction is expected to close in the second quarter.Cannabis stocks jumped on the news, with shares in Cassava Sciences, Sundial Growers, and Tilray closing up 59%, 16%, and 12%, respectively, on Wednesday.Cannabis investors are also optimistic after three Democratic Senators released a statement supporting the decriminalization of marijuana.GW’s drug Epidiolex is used to treat rare forms of epilepsy and had global sales of $510 million within two years of its 2018 launch. The deal will strengthen Jazz’s neuroscience portfolio, said Jazz CEO and Chairman Bruce Cozadd.\"We have a shared vision of developing and commercializing innovative medicines that address significant unmet needs in neuroscience and an approach of putting patients first,” GW CEO Justin Gover said. “Together, we will have an opportunity to reach and impact more patients through a broader portfolio of neuroscience-focused therapies than ever before.\"Shares in GW closed upy 44.5% on the news Wednesday, while shares in Jazz closed down nearly 4%.Article SourcesInvestopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in oureditorial policy.Jazz Pharmaceuticals. \"Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader.\" Accessed Feb. 3, 2021.The Wall Street Journal. \"Jazz Pharmaceuticals to Buy Cannabis-Based Drugmaker GW Pharma for $6.7 Billion.\" Accessed Feb 3, 2021.Compare AccountsAdvertiser Disclosure×The offers that appear in this table are from partnerships from which Investopedia receives compensation.ProviderNameDescriptionAbout UsTerms of UseDictionaryEditorial PolicyAdvertiseNewsPrivacy PolicyContact UsCareersCalifornia Privacy Notice#ABCDEFGHIJKLMNOPQRSTUVWXYZInvestopedia is part of the Dotdash publishing family.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1305,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/317715782"}
精彩评论